髓細胞觸發(fā)受體1(TREM1)重組蛋白
Recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)
CD354; Triggering Receptor Expressed On Monocytes-1
- 編號RPA213Bo01
- 物種Bos taurus; Bovine (Cattle，牛)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜
- 預(yù)測分子量26.5kDa
- 實際分子量20kDa(差異分析請參閱說明書)
- 片段與標簽Ala22~Ser232 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 97%
- 等電點9.2
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1128¥ 2820¥ 5640¥ 16920¥ 42300
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. Gene Sequencing (Extract)
SDS-PAGE圖
通過ISO 9001、ISO 13485質(zhì)量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Bos taurus; Bovine (Cattle，牛) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA213Bo01 | 髓細胞觸發(fā)受體1(TREM1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA213Bo01 | 髓細胞觸發(fā)受體1(TREM1)多克隆抗體 | WB; IHC; ICC; IP. |
| PGA213Bo01 | 髓細胞觸發(fā)受體1(TREM1)引物對 | PCR |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages[Aspet: 171462] |
| Arthritis Research & Therapy | Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine.[pubmed:27624724] |
| Chinese medical journal | Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8+ T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis[PMC5443028] |
| Journal of Maternal-Fetal?&?Neonatal?Medicine | Increased TLR4 and TREM-1 expression on monocytes and neutrophils in preterm birth: further evidence of a proinflammatory state[Pubmed:29534643] |
| Journal of Maternal-Fetal & Neonatal Medicine | A promising novel biomarker for early-onset preeclampsia: soluble trigger receptor expressed on myeloid cells-1 (sTREM-1)[Pubmed: 33207989] |
| Ioannis Gkougkourellas, Alexandros Sarantopoulos, Konstantinos Tselios, Athanasios Kalogeridis[] |